Search Results - "Kasselman, Lora"

Refine Results
  1. 1

    The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity by Kasselman, Lora J., Vernice, Nicholas A., DeLeon, Joshua, Reiss, Allison B.

    Published in Atherosclerosis (01-04-2018)
    “…Cardiovascular disease associated with obesity and autoimmunity is the leading cause of death in these populations and significant residual risk remains…”
    Get full text
    Journal Article
  2. 2

    The Microbiome by Kasselman, Lora

    Published 2020
    “…The Microbiome, Volume 176, assembles known facts and provides guidance for their implementation on topics relating to associations between the gut microbiome…”
    Get full text
    eBook
  3. 3

    Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target by Behbodikhah, Jennifer, Ahmed, Saba, Elyasi, Ailin, Kasselman, Lora J., De Leon, Joshua, Glass, Amy D., Reiss, Allison B.

    Published in Metabolites (08-10-2021)
    “…Apolipoprotein (apo) B, the critical structural protein of the atherogenic lipoproteins, has two major isoforms: apoB48 and apoB100. ApoB48 is found in…”
    Get full text
    Journal Article
  4. 4

    Assessing the performance of ChatGPT in bioethics: a large language model's moral compass in medicine by Chen, Jamie, Cadiente, Angelo, Kasselman, Lora J, Pilkington, Bryan

    Published in Journal of medical ethics (01-02-2024)
    “…Chat Generative Pre-Trained Transformer (ChatGPT) has been a growing point of interest in medical education yet has not been assessed in the field of…”
    Get more information
    Journal Article
  5. 5

    CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies by Reiss, Allison B., Miyawaki, Nobuyuki, Moon, Jane, Kasselman, Lora J., Voloshyna, Iryna, D'Avino, Robert, De Leon, Joshua

    Published in Atherosclerosis (01-11-2018)
    “…Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD) characterized by disruption of normal mineral homeostasis within the body…”
    Get full text
    Journal Article
  6. 6

    Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches by Glass, Daniel S., Grossfeld, David, Renna, Heather A., Agarwala, Priya, Spiegler, Peter, Kasselman, Lora J., Glass, Amy D., DeLeon, Joshua, Reiss, Allison B.

    Published in Respiratory investigation (01-09-2020)
    “…Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease with high mortality that commonly occurs in middle-aged and older adults. IPF,…”
    Get full text
    Journal Article
  7. 7

    PCSK9 in cholesterol metabolism: from bench to bedside by Reiss, Allison B, Shah, Neal, Muhieddine, Dalia, Zhen, Juan, Yudkevich, Jennifer, Kasselman, Lora J, DeLeon, Joshua

    Published in Clinical science (1979) (15-06-2018)
    “…Dyslipidemia, and specifically elevated low-density lipoprotein (LDL) cholesterol, is one of the most important cardiovascular risk factors. Statins are…”
    Get more information
    Journal Article
  8. 8

    Adenosine and the Cardiovascular System by Reiss, Allison B., Grossfeld, David, Kasselman, Lora J., Renna, Heather A., Vernice, Nicholas A., Drewes, Wendy, Konig, Justin, Carsons, Steven E., DeLeon, Joshua

    “…Adenosine is an endogenous nucleoside with a short half-life that regulates many physiological functions involving the heart and cardiovascular system. Among…”
    Get full text
    Journal Article
  9. 9

    The role of interferon-γ in cardiovascular disease: an update by Elyasi, Ailin, Voloshyna, Iryna, Ahmed, Saba, Kasselman, Lora J., Behbodikhah, Jennifer, De Leon, Joshua, Reiss, Allison B.

    Published in Inflammation research (01-10-2020)
    “…Purpose Cardiovascular disease (CVD) is the leading cause of death, globally, and its prevalence is only expected to rise due to the increasing incidence of…”
    Get full text
    Journal Article
  10. 10

    Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer’s Disease, and Other Dementias by Ding, Helen, Reiss, Allison B, Pinkhasov, Aaron, Kasselman, Lora J

    Published in Medicina (Kaunas, Lithuania) (30-07-2022)
    “…Background and Objectives: Alzheimer’s disease (AD) is the most common form of dementia, with the risk of developing it attributed to non-modifiable and…”
    Get full text
    Journal Article
  11. 11

    Cognitive Function and the Consumption of Probiotic Foods: A National Health and Nutrition Examination Survey Study by Kasselman, Lora J, Peltier, Morgan R, De Leon, Joshua, Reiss, Allison B

    Published in Nutrients (25-10-2024)
    “…Background/Objectives: Impaired cognition is a key trait of the diseases of aging and is an important quality of life factor for older adults and their…”
    Get full text
    Journal Article
  12. 12

    An Assessment of the Ocular Toxicity of Two Major Sources of Environmental Exposure by Rauchman, Steven H, Kasselman, Lora J, Srivastava, Ankita, De Leon, Joshua, Reiss, Allison B

    “…The effect of airborne exposure on the eye surface is an area in need of exploration, particularly in light of the increasing number of incidents occurring in…”
    Get full text
    Journal Article
  13. 13

    Accelerated Atherosclerosis in Rheumatoid Arthritis: Mechanisms and Treatment by Reiss, Allison B, Silverman, Andrew, Khalfan, Muhammed, Vernice, Nicholas A, Kasselman, Lora J, Carsons, Steven E, De Leon, Joshua

    Published in Current pharmaceutical design (01-01-2019)
    “…Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disorder that increases the risk of developing cardiovascular disease. There is…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Acute Kidney Injury in Rhabdomyolysis: A 5-Year Children's Hospital Network Study by Pinto, Jamie M, Ison, Gregory, Kasselman, Lora J, Naganathan, Srividya

    Published in Healthcare (Basel) (28-08-2024)
    “…Rhabdomyolysis is a skeletal muscle injury that can cause myoglobinuria and acute kidney injury (AKI). Risk factors for AKI in children are not clearly…”
    Get full text
    Journal Article
  16. 16

    Cholesterol deficiency as a mechanism for autism: A valproic acid model by Peltier, Morgan R., Behbodikhah, Jennifer, Renna, Heather A., Ahmed, Saba, Srivastava, Ankita, Arita, Yuko, Kasselman, Lora J., Pinkhasov, Aaron, Wisniewski, Thomas, De Leon, Joshua, Reiss, Allison B.

    Published in Journal of investigative medicine (01-01-2024)
    “…Dysregulated cholesterol metabolism represents an increasingly recognized feature of autism spectrum disorder (ASD). Children with fetal valproate syndrome…”
    Get full text
    Journal Article
  17. 17

    Oxytocin: Potential to mitigate cardiovascular risk by Reiss, Allison B., Glass, Daniel S., Lam, Eric, Glass, Amy D., De Leon, Joshua, Kasselman, Lora J.

    Published in Peptides (New York, N.Y. : 1980) (01-07-2019)
    “…•Oxytocin may be a candidate treatment for cardiovascular disease.•Oxytocin has effects beyond the reproductive system.•Atheroprotection by oxytocin occurs…”
    Get full text
    Journal Article
  18. 18

    Dementia and Diet, Methodological and Statistical Issues: A Pilot Study by Stecker, Mark, Stecker, Mona, Reiss, Allison B., Kasselman, Lora

    Published in Frontiers in aging neuroscience (06-07-2022)
    “…There is conflicting information on the relationship between diet and dementia. The purposes of this pilot study were twofold. First, to use publicly available…”
    Get full text
    Journal Article
  19. 19

    Ongoing Use of SSRIs Does Not Alter Outcome in Hospitalized COVID-19 Patients: A Retrospective Analysis by Rauchman, Steven H, Mendelson, Sherri G, Rauchman, Courtney, Kasselman, Lora J, Pinkhasov, Aaron, Reiss, Allison B

    Published in Journal of clinical medicine (24-12-2021)
    “…SARS-CoV-2 continues to have devastating consequences worldwide. Though vaccinations have helped reduce spread, new strains still pose a threat. Therefore, it…”
    Get full text
    Journal Article
  20. 20

    Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A by Voloshyna, Iryna, Teboul, Isaac, Kasselman, Lora J., Salama, Michael, Carsons, Steven E., DeLeon, Joshua, Mattana, Joseph, Miyawaki, Nobuyuki, Reiss, Allison B.

    Published in Inflammation research (01-09-2019)
    “…Objective Mycophenolate (MPA) and cyclosporin A (CsA) are two immunosuppressive agents currently used for the treatment of autoimmune diseases. However,…”
    Get full text
    Journal Article